普洛藥(yao)(yao)業股份(fen)有(you)限公司是(shi)一家醫(yi)藥(yao)(yao)企業。2001年在深交所主板上市,是(shi)橫店集團醫(yi)藥(yao)(yao)產(chan)(chan)業產(chan)(chan)融結合平臺。
公司從事醫藥產(chan)品的研(yan)發、生產(chan)和銷(xiao)(xiao)售(shou)。主(zhu)要業(ye)(ye)務有原料藥(API)業(ye)(ye)務、合同研(yan)發生產(chan)服務(CDMO)業(ye)(ye)務和制劑(FDF)業(ye)(ye)務,產(chan)品主(zhu)要集(ji)中在心(xin)腦血管、抗感染、抗腫(zhong)瘤(liu)等治(zhi)療(liao)領域。目前(qian),原料規模化生產(chan)品種70余個,銷(xiao)(xiao)售(shou)過億(yi)品種有11個,羥(qian)酸(suan)、安(an)非、沙(sha)坦、D-乙酯(zhi)等品種占(zhan)全球市場(chang)絕對份額。
公(gong)司總部(bu)位于浙江省東陽市(shi)橫(heng)店鎮,有7家(jia)原料藥(yao)生(sheng)產(chan)工廠(chang)(chang)和4家(jia)制(zhi)劑生(sheng)產(chan)工廠(chang)(chang),分布(bu)在(zai)浙江橫(heng)店、浙江衢州、山東濰坊、安徽池州、山西大(da)同等地(di);在(zai)公(gong)司總部(bu)以及上海、成都(dou)、杭州設(she)(she)立了研發機(ji)構;在(zai)美國、香港設(she)(she)立了境外公(gong)司或分支機(ji)構。
為確立市場(chang)競爭(zheng)優勢(shi),公司(si)持續打造質量、EHS和技術(shu)核心競爭(zheng)力。原料藥(yao)工(gong)廠(chang)(chang)有5家(jia)(jia)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)GMP認(ren)(ren)(ren)(ren)證(zheng),有4 家(jia)(jia)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)FDA認(ren)(ren)(ren)(ren)證(zheng),3家(jia)(jia)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)PMDA認(ren)(ren)(ren)(ren)證(zheng),3家(jia)(jia)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)歐盟CE認(ren)(ren)(ren)(ren)證(zheng),1家(jia)(jia)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)世(shi)衛組織WHO認(ren)(ren)(ren)(ren)證(zheng),1家(jia)(jia)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)KFDA認(ren)(ren)(ren)(ren)證(zheng),1家(jia)(jia)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)德國GMP認(ren)(ren)(ren)(ren)證(zheng);制(zhi)劑工(gong)廠(chang)(chang)均通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)GMP認(ren)(ren)(ren)(ren)證(zheng)。原料藥(yao)工(gong)廠(chang)(chang)除通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)安(an)全與(yu)職業健康(kang)管理體(ti)系認(ren)(ren)(ren)(ren)證(zheng)外(wai),還不斷接受并(bing)通(tong)(tong)(tong)(tong)(tong)(tong)過(guo)(guo)國際制(zhi)藥(yao)公司(si)或第三方的EHS審計。
公(gong)司秉持“共創、共有、共富、共享”的核心價值(zhi),著力打造“快(kuai)樂(le)學習、快(kuai)樂(le)運動(dong)、快(kuai)樂(le)工作”的芒果视(shi)频(pin),實施“做(zuo)精原(yuan)料、做(zuo)強CDMO、做(zuo)優(you)制劑”的發(fa)展戰略(lve),以(yi)文化推(tui)動(dong)創新,以(yi)創新驅動(dong)未來。愿與社會各界攜手,為(wei)實現“健康夢”做(zuo)出更大貢獻。